Thermo Fisher Scientific Announces Final Purchase Price for Cash Tender Offer for Convertible Notes
December 17, 2009
WALTHAM, Mass.--Thermo Fisher Scientific Inc. (NYSE: TMO) announced today that it has determined the final purchase price offered by the company pursuant to its previously announced tender offer (the “Offer”) to purchase for cash any and all of its outstanding 2.50% Convertible Senior Notes due 2023 (the “Convertible Notes”). The final purchase price per $1,000 [...]
Simulations Plus Appoints John DiBella, M.S. Manager, Marketing and Sales
December 17, 2009
New Leadership Brings Strength in Science and Engineering LANCASTER, Calif.--Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of simulation and modeling software to the pharmaceutical industry, announces the appointment of Mr. John DiBella as manager of marketing and sales, reporting to Dr. Michael Pelekis, director of business development, marketing, and sales. Walt Woltosz, chairman and chief [...]
Xenomics’ Preliminary Investigation
December 17, 2009
Investigation Leads the Company to Believe Sequenom Willfully Manipulated its Down Syndrome Data in its Presentations NEW YORK--Xenomics, Inc. (XNOM.PK), a developer of transrenal molecular diagnostics, announced today that an ongoing internal investigation by Xenomics’ personnel of the events surrounding its licensing deal with Sequenom (Nasdaq:SQNM) in late October, 2008 leads it to conclude that [...]
Thermo Fisher Scientific Provides Enhanced Drinking Water Analysis in Compliance with US EPA Methods
December 17, 2009
Using Comprehensive Environmental GC/MS Productivity Solutions AUSTIN, TEXAS -- Thermo Fisher Scientific Inc., the world leader in serving science, today announced enhanced drinking water analytical capabilities of the Thermo Scientific Environmental GC/MS Online Productivity Solutions with respect to United States Environmental Protection Agency (US EPA) Methods 524.2 and 525.2. The powerful Thermo Scientific 524 and [...]
BioTek Instruments Expands World Headquarters
December 17, 2009
WINOOSKI VT, USA — BioTek Instruments recently announced the expansion of its world headquarters in Winooski, Vermont, USA. The company added 8,000 square feet; effectively increasing the size of its Service department by 50% and housing a new applications laboratory. Additionally, existing space will be repurposed to manufacturing; providing space for the company’s new product [...]
CLC bio Releases Beta Version of Super Fast de novo Assembler
December 17, 2009
AARHUS, Denmark--Last week CLC bio released the beta version of their long awaited assembly algorithm for de novo assembly to selected customers and now it’s publically available. The new assembler comes in two different editions, as a standalone command-line interface and as a graphical user interface through a plug-in for CLC Genomics Workbench. User Experience [...]
FDA Broadens Clearance for Agendia’s MammaPrint(R)
December 17, 2009
HUNTINGTON BEACH, California and AMSTERDAM -- Agendia, a world leader in molecular cancer diagnostics, announced today that the US Food and Drug Administration (FDA) cleared its MammaPrint breast cancer recurrence test for all ages. MammaPrint is the only FDA-cleared breast cancer recurrence test available to patients and physicians. Over the past three years, the FDA [...]
December 17, 2009
Low-level Mitochondrial DNA Variants are Linked to Disease OMAHA, Neb., December 17, 2009 - Transgenomic, Inc. (OTC BB: TBIO.OB) announced today that it has reached agreement with Gene Solutions for an exclusive licensing option to a set of validated mutations found in Parkinson’s disease patients that can form the basis of a novel and accurate [...]
Roche Diagnostics Licenses Melting Curve Analysis and SYBR Green Techniques to Takara Bio
December 17, 2009
PENZBERG, Germany & SHIGA, Japan--Roche Diagnostics (SWX:RO) (SWX:ROG) (Pink Sheets: RHHBY) and Takara Bio (TSE Mothers: 4974), the Shiga (Japan)-based supplier of systems for use in life science research, announced that they have entered into a license agreement for use of the melting curve analysis technology and SYBR Green techniques in their Kits and Instruments [...]
Cellectis bioresearch launches first kit from cGPS® Custom line for use in human cell lines.
December 17, 2009
Paris -- Cellectis bioresearch, a specialist in genome customization and a subsidiary of Cellectis S.A. (Alternext: ALCLS), has today announced the launch of cGPS® Custom HEK293, its first research kit that can be used on cell lines derived from human material. The new cGPS® Custom kit will allow scientists to control the expression of any [...]

